NewsBenzingaIDEAYA Biosciences、第3四半期EPSは(1.22ドル)で予想(1.18ドル)を下回る、売上高は1,024.2万ドルで予想685.7万ドルを上回る IDEAYA Biosciences、第3四半期EPSは(1.22ドル)で予想(1.18ドル)を下回る、売上高は1,024.2万ドルで予想685.7万ドルを上回る Benzinga 2026.11.03 11:15 (GMT+0) Open on Benzinga Other news Jim Cramer Likes This Industrial Stock: ‘It’s Come Down A Great Deal’ These Analysts Revise Their Forecasts On Palantir After Q3 Results Xiaomi Discloses 8-Hour Humanoid Robot Factory Work and Long-Horizon Home Task Progress Needham Reiterates Buy on ON Semiconductor, Maintains $116 Price Target Zebra Technologies Narrows FY2026 Adj EPS Guidance from $20.75-$21.25 to $21.20 vs $20.89 Est; Raises FY2026 Sales Guidance from $6.151B-$6.259B to $6.313B vs $6.212B Est Hydrofarm Eliminates $109M Term Loan After Recapitalization
Zebra Technologies Narrows FY2026 Adj EPS Guidance from $20.75-$21.25 to $21.20 vs $20.89 Est; Raises FY2026 Sales Guidance from $6.151B-$6.259B to $6.313B vs $6.212B Est
